Selected research
Market Outlook & Growth Opportunities
Global Sore Throat Remedies Market Outlook and Growth Opportunities 2026
Market perspective
The global Sore Throat Remedies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Sore Throat Remedies market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Sore Throat Remedies market include Sun Pharmaceutical, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer AG, AstraZeneca, Reckitt Benckiser Group and Procter & Gamble, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Sore Throat Remedies market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sore Throat Remedies and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sore Throat Remedies revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Sore Throat Remedies market.
Sore Throat Remedies Segment by Company
Sun Pharmaceutical
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer AG
AstraZeneca
Reckitt Benckiser Group
Procter & Gamble
Prestige Brands Holdings
Sore Throat Remedies Segment by Type
Tablets/Pills
Oral Syrup
Lozenges
Others
Sore Throat Remedies Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce/Online Pharmacies
Others
Sore Throat Remedies Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Sore Throat Remedies status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Sore Throat Remedies key companies, revenue, market share, and recent developments.
3. To split the Sore Throat Remedies breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Sore Throat Remedies market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Sore Throat Remedies significant trends, drivers, influence factors in global and regions.
6. To analyze Sore Throat Remedies competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sore Throat Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sore Throat Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sore Throat Remedies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sore Throat Remedies industry.
Chapter 3: Detailed analysis of Sore Throat Remedies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Sore Throat Remedies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Sore Throat Remedies in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets/Pills
- Oral Syrup
- Lozenges
- Others
Applications
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce/Online Pharmacies
- Others
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Novartis
- Pfizer
- GlaxoSmithKline
- Bayer AG
- AstraZeneca
- Reckitt Benckiser Group
- Procter & Gamble
- Prestige Brands Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sore Throat Remedies Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sore Throat Remedies Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sore Throat Remedies Market Dynamics
- 2.1 Sore Throat Remedies Industry Trends
- 2.2 Sore Throat Remedies Industry Drivers
- 2.3 Sore Throat Remedies Industry Opportunities and Challenges
- 2.4 Sore Throat Remedies Industry Restraints
3 Sore Throat Remedies Market by Company
- 3.1 Global Sore Throat Remedies Company Revenue Ranking in 2025
- 3.2 Global Sore Throat Remedies Revenue by Company (2021-2026)
- 3.3 Global Sore Throat Remedies Company Ranking (2024-2026)
- 3.4 Global Sore Throat Remedies Company Manufacturing Base and Headquarters
- 3.5 Global Sore Throat Remedies Company Product Type and Application
- 3.6 Global Sore Throat Remedies Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Sore Throat Remedies Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Sore Throat Remedies Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Sore Throat Remedies Market by Type
- 4.1 Sore Throat Remedies Type Introduction
- 4.1.1 Tablets/Pills
- 4.1.2 Oral Syrup
- 4.1.3 Lozenges
- 4.1.4 Others
- 4.2 Global Sore Throat Remedies Sales Value by Type
- 4.2.1 Global Sore Throat Remedies Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sore Throat Remedies Sales Value by Type (2021-2032)
- 4.2.3 Global Sore Throat Remedies Sales Value Share by Type (2021-2032)
5 Sore Throat Remedies Market by Application
- 5.1 Sore Throat Remedies Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Retail Pharmacies
- 5.1.3 E-Commerce/Online Pharmacies
- 5.1.4 Others
- 5.2 Global Sore Throat Remedies Sales Value by Application
- 5.2.1 Global Sore Throat Remedies Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sore Throat Remedies Sales Value by Application (2021-2032)
- 5.2.3 Global Sore Throat Remedies Sales Value Share by Application (2021-2032)
6 Sore Throat Remedies Regional Value Analysis
- 6.1 Global Sore Throat Remedies Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sore Throat Remedies Sales Value by Region (2021-2032)
- 6.2.1 Global Sore Throat Remedies Sales Value by Region: 2021-2026
- 6.2.2 Global Sore Throat Remedies Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sore Throat Remedies Sales Value (2021-2032)
- 6.3.2 North America Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Sore Throat Remedies Sales Value (2021-2032)
- 6.4.2 Europe Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Sore Throat Remedies Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Sore Throat Remedies Sales Value (2021-2032)
- 6.6.2 South America Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Sore Throat Remedies Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
7 Sore Throat Remedies Country-level Value Analysis
- 7.1 Global Sore Throat Remedies Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Sore Throat Remedies Sales Value by Country (2021-2032)
- 7.2.1 Global Sore Throat Remedies Sales Value by Country (2021-2026)
- 7.2.2 Global Sore Throat Remedies Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.7.2 France Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.14.2 China Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.17.2 India Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Sore Throat Remedies Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical
- 8.1.1 Sun Pharmaceutical Company Information
- 8.1.2 Sun Pharmaceutical Business Overview
- 8.1.3 Sun Pharmaceutical Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Sore Throat Remedies Product Portfolio
- 8.1.5 Sun Pharmaceutical Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Sore Throat Remedies Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Sore Throat Remedies Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Pfizer
- 8.4.1 Pfizer Company Information
- 8.4.2 Pfizer Business Overview
- 8.4.3 Pfizer Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Sore Throat Remedies Product Portfolio
- 8.4.5 Pfizer Recent Developments
- 8.5 GlaxoSmithKline
- 8.5.1 GlaxoSmithKline Company Information
- 8.5.2 GlaxoSmithKline Business Overview
- 8.5.3 GlaxoSmithKline Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.5.4 GlaxoSmithKline Sore Throat Remedies Product Portfolio
- 8.5.5 GlaxoSmithKline Recent Developments
- 8.6 Bayer AG
- 8.6.1 Bayer AG Company Information
- 8.6.2 Bayer AG Business Overview
- 8.6.3 Bayer AG Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.6.4 Bayer AG Sore Throat Remedies Product Portfolio
- 8.6.5 Bayer AG Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca Sore Throat Remedies Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Reckitt Benckiser Group
- 8.8.1 Reckitt Benckiser Group Company Information
- 8.8.2 Reckitt Benckiser Group Business Overview
- 8.8.3 Reckitt Benckiser Group Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.8.4 Reckitt Benckiser Group Sore Throat Remedies Product Portfolio
- 8.8.5 Reckitt Benckiser Group Recent Developments
- 8.9 Procter & Gamble
- 8.9.1 Procter & Gamble Company Information
- 8.9.2 Procter & Gamble Business Overview
- 8.9.3 Procter & Gamble Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.9.4 Procter & Gamble Sore Throat Remedies Product Portfolio
- 8.9.5 Procter & Gamble Recent Developments
- 8.10 Prestige Brands Holdings
- 8.10.1 Prestige Brands Holdings Company Information
- 8.10.2 Prestige Brands Holdings Business Overview
- 8.10.3 Prestige Brands Holdings Sore Throat Remedies Revenue and Gross Margin (2021-2026)
- 8.10.4 Prestige Brands Holdings Sore Throat Remedies Product Portfolio
- 8.10.5 Prestige Brands Holdings Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst